Angiographic Findings and Post–Percutaneous Coronary Intervention Fractional Flow Reserve

Author:

Zhang Jinlong1,Hwang Doyeon2,Yang Seokhun2,Hu Xinyang1,Lee Joo Myung3,Nam Chang-Wook4,Shin Eun-Seok5,Doh Joon-Hyung6,Hoshino Masahiro7,Hamaya Rikuta7,Kanaji Yoshihisa7,Murai Tadashi7,Zhang Jun-Jie8,Ye Fei8,Li Xiaobo8,Ge Zhen8,Chen Shao-Liang8,Kakuta Tsunekazu7,Wang Jian’an1,Koo Bon-Kwon2

Affiliation:

1. Department of Cardiology, Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China

2. Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea

3. Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

4. Department of Cardiology, Keimyung University Dongsan Medical Center, Daegu, Korea

5. Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

6. Department of Cardiology, Inje University Ilsan Paik Hospital, Goyang, Korea

7. Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan

8. Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

Abstract

ImportanceThe associations between angiographic findings and post–percutaneous coronary intervention (PCI) fractional flow reserve (FFR) and their clinical relevance according to residual functional disease burden have not been thoroughly investigated.ObjectivesTo evaluate the association of angiographic and physiologic parameters according to residual functional disease burden after drug-eluting stent implantation.Design, Setting, and ParticipantsThis cohort study population was from the International Post-PCI FFR registry, which incorporated 4 registries from Korea, China, and Japan. Patients who underwent angiographically successful second-generation drug-eluting stent implantation and post-PCI FFR measurement were included in the analysis. The patients were divided into 3 groups according to the residual disease burden (post-PCI FFR ≤0.80 [residual ischemia], 0.81-0.86 [suboptimal], and >0.86 [optimal]). The data were collected from August 23, 2018, to June 11, 2019, and the current analysis was performed from January 11, 2022, to October 7, 2023.ExposuresAngiographic parameters and post-PCI FFR.Main Outcomes and MeasuresThe primary outcome was target vessel failure (TVF), defined as a composite of cardiac death, target vessel–related myocardial infarction, and target vessel revascularization (TVR) at 2 years.ResultsIn this cohort of 2147 patients, the mean (SD) age was 64.3 (10.0) years, and 1644 patients (76.6%) were men. Based on the post-PCI physiologic status, 269 patients (12.5%) had residual ischemia, 551 (25.7%) had suboptimal results, and 1327 (61.8%) had optimal results. Angiographic parameters had poor correlations with post-PCI FFR (r < 0.20). Post-PCI FFR was isolated from all angiographic parameters in the unsupervised hierarchical cluster analysis. Post-PCI FFR was associated with the occurrence of TVF (adjusted hazard ratio [AHR] per post-PCI FFR 0.01 increase, 0.94 [95% CI, 0.92-0.97]; P < .001), but angiographic parameters were not. The residual ischemia group had a significantly higher rate of TVF than the suboptimal group (AHR, 1.75 [95% CI, 1.08-2.83]; P = .02) and the optimal group (AHR, 2.94 [95% CI, 1.82-4.73]; P < .001). The TVR in the residual ischemia group was predominantly associated with TVR in the nonstented segment (14 [53.8%]), unlike the other 2 groups (3 [10.0%] in the suboptimal group and 13 [30.2%] in the optimal group).Conclusions and RelevanceIn this cohort study of the International Post-PCI FFR registry, a low degree of associations were observed between angiographic and physiologic parameters after PCI. Post-PCI FFR, unlike angiographic parameters, was associated with clinical events and the distribution of clinical events. The current study supports the use of post-PCI FFR as a procedural quality metric and further prospective study is warranted.

Publisher

American Medical Association (AMA)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3